# Study of Laser Treatment of Melasma

> **NCT01335581** · NA · COMPLETED · sponsor: **ConBio, a Cynosure Company** · enrollment: 18 (actual)

## Conditions studied

- Refractory Mixed Type Melasma

## Interventions

- **DEVICE:** Q-Switched Nd:YAG Laser (RevLite)
- **DRUG:** Retin-A and microdermabrasion

## Key facts

- **NCT ID:** NCT01335581
- **Lead sponsor:** ConBio, a Cynosure Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01335581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01335581, "Study of Laser Treatment of Melasma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01335581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*